摘要
<strong>Objective:</strong><b><span style="font-family:;" "=""> </span></b><span style="font-family:;" "="">The aim was to take stock of the screening and treatment of precancerous and cancerous lesions of the cervix in the health district of commune V of Bamako, the </span><span style="font-family:;" "="">“</span><span style="font-family:;" "="">G</span><span style="font-family:;" "="">”</span><span style="font-family:;" "=""> point and the Gabriel Touré University Hospital <span>in Bamako, Mali. <b>Patients and Methods:</b> This was a descriptive, cross-sectional</span>, analytical study with retrospective and prospective data collection over an 8-year period from January 1, 2010 to December 31, 2017. This was a multi-center study. <b>Results: </b>From January 1, 2010 to December 31, 2017, 42</span><span style="font-family:;" "="">,</span><span style="font-family:;" "="">492 women were screened, representing a frequency of 24.30%. The median age of the women screened was 32 years;25% were under the age of 25. Three-fourth of the women screened was in the 20</span><span style="font-family:;" "=""> </span><span style="font-family:;" "="">-</span><span style="font-family:;" "=""> </span><span style="font-family:;" "="">49 age group. Of the 22</span><span style="font-family:;" "="">,</span><span style="font-family:;" "="">842 women screened</span><span style="font-family:;" "="">,</span><span style="font-family:;" "=""> 90.1% of them had a normal col to IVA/IVL. However</span><span style="font-family:;" "="">,</span><span style="font-family:;" "=""> 4.1% of cervical positivity </span><span style="font-family:;" "="">had </span><span style="font-family:;" "="">with acetic acid and 5.1% of positivity to Lugol. 0.7% of the women screened clinically had cancerous lesions. Histologically, 96.5% of the women screened had a normal cervix with benign lesions. For pathological histological findings, we noted 2.6% of precancerous lesions and 0.8% of squamous cell carcinomas and 0.1% of adenocarcinoma. <b>Conclusion: </b>Improved screening indicators with IVA/IV reduce the rate of morbidity and mortality from cervical cancer.</span>
<strong>Objective:</strong><b><span style="font-family:;" "=""> </span></b><span style="font-family:;" "="">The aim was to take stock of the screening and treatment of precancerous and cancerous lesions of the cervix in the health district of commune V of Bamako, the </span><span style="font-family:;" "="">“</span><span style="font-family:;" "="">G</span><span style="font-family:;" "="">”</span><span style="font-family:;" "=""> point and the Gabriel Touré University Hospital <span>in Bamako, Mali. <b>Patients and Methods:</b> This was a descriptive, cross-sectional</span>, analytical study with retrospective and prospective data collection over an 8-year period from January 1, 2010 to December 31, 2017. This was a multi-center study. <b>Results: </b>From January 1, 2010 to December 31, 2017, 42</span><span style="font-family:;" "="">,</span><span style="font-family:;" "="">492 women were screened, representing a frequency of 24.30%. The median age of the women screened was 32 years;25% were under the age of 25. Three-fourth of the women screened was in the 20</span><span style="font-family:;" "=""> </span><span style="font-family:;" "="">-</span><span style="font-family:;" "=""> </span><span style="font-family:;" "="">49 age group. Of the 22</span><span style="font-family:;" "="">,</span><span style="font-family:;" "="">842 women screened</span><span style="font-family:;" "="">,</span><span style="font-family:;" "=""> 90.1% of them had a normal col to IVA/IVL. However</span><span style="font-family:;" "="">,</span><span style="font-family:;" "=""> 4.1% of cervical positivity </span><span style="font-family:;" "="">had </span><span style="font-family:;" "="">with acetic acid and 5.1% of positivity to Lugol. 0.7% of the women screened clinically had cancerous lesions. Histologically, 96.5% of the women screened had a normal cervix with benign lesions. For pathological histological findings, we noted 2.6% of precancerous lesions and 0.8% of squamous cell carcinomas and 0.1% of adenocarcinoma. <b>Conclusion: </b>Improved screening indicators with IVA/IV reduce the rate of morbidity and mortality from cervical cancer.</span>
作者
Soumana Oumar Traoré
Saleck Doumbia
Cheickna Sylla
Saoudatou Tall
Ibrahima Tegueté
Ichiaka Djibo
Faissif Kouyaté
Issa Ongoiba
Youssouf Traore
Oumar Moussokoro Traore
Niani Mounkoro
Mamadou Traore
Soumana Oumar Traoré;Saleck Doumbia;Cheickna Sylla;Saoudatou Tall;Ibrahima Tegueté;Ichiaka Djibo;Faissif Kouyaté;Issa Ongoiba;Youssouf Traore;Oumar Moussokoro Traore;Niani Mounkoro;Mamadou Traore(Faculty of Medicine and Odontostomatology, University of Science and Technology, Bamako, Mali;Department of Gynecology and Obstetrics, Reference Health Centre of Commune V, Bamako, Mali;Department of Obstetrics and Gynecology, Koutiala Reference Health Centre, Sikasso, Mali;Department of Gynecology and Obstetrics, Gabriel Touré University Hospital, Bamako, Mali)